Tag Archives: Johnson Controls Inc.

New Inversion Rules Test Pending Deals, WSJ Reports

The U.S. Treasury Department’s latest attempt at stopping corporate inversions last week spelled doom for Pfizer Inc.’s (New York City) $150 billion attempted takeover of Allergan PLC (Dublin IRL)–what would… Read more »